Welcome to our dedicated page for Innovate SEC filings (Ticker: VATE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Three businesses—steel construction, cutting-edge medical devices, and over-the-air broadcasting—sit inside Innovate Corp’s (NYSE: VATE) 300-page annual report. Finding where DBM Global’s project backlog ends and Pansend’s clinical-trial costs begin can be a full-time job. That’s why this page surfaces every Innovate Corp SEC filing explained simply, from spectrum-license 8-K updates to life-sciences R&D spend hidden in footnotes.
Our AI reads each new document the moment it hits EDGAR, then delivers plain-English answers to the questions professionals ask most: “Where is the Innovate Corp quarterly earnings report 10-Q filing?”, “Show me Innovate Corp insider trading Form 4 transactions”, or “How does the latest 8-K affect segment revenue guidance?” You’ll see instant summaries, red-flag highlights, and side-by-side metrics—so you can compare steel-fabrication margins, drug-development milestones, and broadcast cash flow without scrolling through exhibits.
Whether you monitor Innovate Corp executive stock transactions Form 4, need the Innovate Corp proxy statement executive compensation tables, or want the Innovate Corp annual report 10-K simplified, everything is here in real time. Click into any filing type—10-K, 10-Q, 8-K, S-4, or Form 4—and our platform shows how each disclosure connects back to infrastructure backlog, FDA submissions, or FCC licence values. No more hunting for footnotes: Stock Titan’s expert analysis translates technical language, tracks material events, and alerts you to Innovate Corp Form 4 insider transactions real-time. Understand Innovate faster, act sooner, and make informed decisions with AI-powered clarity.
INNOVATE Corp. filed an 8-K announcing that its portfolio company, DBM Global, plans to pay a cash dividend. The company issued a press release titled “INNOVATE’s Portfolio Company DBM Global to Pay Cash Dividend” on October 16, 2025, which is attached as Exhibit 99.1.
The press release is furnished and not deemed filed under Section 18 of the Exchange Act, nor incorporated by reference under the Securities Act unless specifically referenced in a future filing. INNOVATE’s common stock trades on the NYSE under the symbol VATE.
INNOVATE Corp. (VATE) Form 4/A shows amended insider reporting by Avram A. Glazer, related trust and affiliates reflecting conversions of company convertible notes. The amendment adds Lancer Capital LLC as an additional reporting owner and clarifies indirect ownership through the Avram Glazer Irrevocable Exempt Trust and familial relationships.
The filing shows convertible instruments with a $42.3143 conversion price. For the 9.5% Convertible Senior Notes due 2027, the filing reports beneficial ownership of 2,195,000 common shares following the reported transaction, held indirectly through Lancer Capital. Signatures are dated 09/18/2025.
Paul Voigt, Interim CEO of INNOVATE Corp. (VATE), reported the grant of three stock option awards on 09/15/2025. Each award covers 100,000 underlying shares of common stock for a total of 300,000 optioned shares, and each is reported as direct ownership. Exercise prices shown are $5.67, $4.22 and $25.00. The $5.67 exercise price was set at 110% of the 10-day VWAP on the grant date, per the filing. Listed exercisability and expiration dates include ranges through 09/15/2035 for one award and earlier expirations for others. The form is signed by Mr. Voigt and filed on 09/17/2025.
INNOVATE Corp. filed a Form D reporting a completed Rule 506(b) exempt offering of newly issued 10.500% Senior Secured Notes due 2027. The filing states the issuer conducted an exchange offer and consent solicitation that exchanged approximately $328.1 million of 8.500% Senior Secured Notes due 2026 for approximately $360.4 million of the new 10.500% Senior Secured Notes. The total offering amount and amount sold are both reported as $360,356,287, with no remaining securities to be sold. The filing lists five investors to date, a $2,000 minimum investment, $0 in sales commissions and finders' fees, and indicates proceeds paid to named officers/directors/promoters as $0. The notice is marked as a new notice with first sale on 2025-07-30 and indicates the offering will not last more than one year.
INNOVATE Corp. (NYSE: VATE) filed an 8-K to disclose preliminary results of its previously announced exchange offer and consent solicitation for its 8.5% Senior Secured Notes due 2026. According to the 31 July 2025 filing (Item 8.01), eligible holders that tendered their notes by 5:00 p.m. ET on 30 July 2025 will receive newly issued 10.5% Senior Secured Notes due 2027 plus the Total Early Exchange Consideration. The company also extended the ability to receive this early-bird consideration through the final Expiration Deadline, aiming to maximise participation. Numeric take-up levels and revised terms were not included in the filing but are expected in Exhibit 99.1 (press release). No other financial statements were furnished. The transaction lowers near-term refinancing pressure by pushing maturity out one year, but comes at a higher coupon, signalling a higher cost of capital.
FAQ
What is the current stock price of Innovate (VATE)?
What is the market cap of Innovate (VATE)?
